6533b7d5fe1ef96bd1265142
RESEARCH PRODUCT
Hybrid minimally invasive esophagectomy for esophageal cancer : less is more
Pieter C. Van Der SluisRichard Van HillegersbergJelle P RuurdaPeter P. Grimmingersubject
Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCommentCancerTransthoracic esophagectomyEsophageal cancermedicine.diseaseSurgerylaw.inventionEditorial CommentaryNew englandmedicine.anatomical_structureEditorialRandomized controlled triallawEsophagectomyInvasive esophagectomymedicineEsophagusbusinessdescription
In a recently published multi-center randomized controlled trial ( New England Journal of Medicine 2019;380:152-162) Christophe Mariette and colleagues compared open transthoracic esophagectomy to hybrid esophagectomy (open thoracic phase, laparoscopic abdominal phase) for patients with resectable cancer of the middle or lower third of the esophagus (MIRO trial) (1).
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-09-01 | Journal of Thoracic Disease |